TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33849715

Group type: EXPERIMENTAL
Intervention: Arm cycling exercise plus traditional physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional physiotherapy programme (control group)
Number of subjects: 30
Study: 35109507

Group type: EXPERIMENTAL
Intervention: Robot-based cognitive intervention (Robot), 60-min session per day for 12 weeks.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist control (control), no cognitive intervention.
Number of subjects: 37
Study: 32215888

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of 200 μg 25OHD followed by daily infusion of 15 μg 25OHD for 10 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34857853

Group type: EXPERIMENTAL
Intervention: Carprofen 4.4 mg/kg/day for 90 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no anti-inflammatory medication)
Number of subjects: 26
Study: 34889491

Group type: EXPERIMENTAL
Intervention: Arm abduction at 30° without cushion support
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Arm abduction at 45° without cushion support
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Arm abduction at 60° without cushion support
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Arm abduction at 30° with cushion support
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Arm abduction at 45° with cushion support
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Arm abduction at 60° with cushion support
Number of subjects: 23
Study: 32325373

Group type: EXPERIMENTAL
Intervention: macimorelin 0.5 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: macimorelin 1.0 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: macimorelin 2.0 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study: 36164180

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 2.5 mg/kg Q3W (Arm A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q3W (Arm B)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 2.5 mg/kg Q6W (Arm C)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q6W (Arm D)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q6W (Arm E)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All Arms (A-E)
Number of subjects: 200
Study: 34098672

Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo vitamin C 100 mg
Number of subjects: 60
Study: 32057687

Group type: EXPERIMENTAL
Intervention: Dance and music
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Music alone
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 93
Study: 35788767

Group type: EXPERIMENTAL
Intervention: PEITEM intervention (1-year, 6-component intervention via video teleconference)
Number of subjects: 1634

Group type: EXPERIMENTAL
Intervention: PEITEM intervention
Number of subjects: 1634

Group type: COMPARATOR
Intervention: Routine care plus stroke registry (control)
Number of subjects: 1634
Study: 33452063

Group type: EXPERIMENTAL
Intervention: Technology-Assisted Language Intervention (TALI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 41
Study: 32798197

Group type: EXPERIMENTAL
Intervention: Pestle needle therapy
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (sham treatment with very light pressure)
Number of subjects: 154
Study: 35644989

Group type: EXPERIMENTAL
Intervention: Single antipyretic use for relief of fever-related discomfort
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Antipyretics for febrile settled child with normal fluid intake
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Antipyretics for reduced fluid intake in febrile settled child
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Advice to give antipyretics to prevent febrile convulsions
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: RCT of antipyretics in febrile children <2 years of age
Number of subjects: 602
Study: 32861819

Group type: EXPERIMENTAL
Intervention: Radiation therapy boost (441 patients, 40.8%)
Number of subjects: 1082

Group type: COMPARATOR
Intervention: No radiation therapy boost (641 patients, 59.2%)
Number of subjects: 1082
Study: 36494054

Group type: EXPERIMENTAL
Intervention: Intravenous sarilumab (200 mg or 400 mg)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 34579125

Group type: EXPERIMENTAL
Intervention: Daily caloric restriction (DCR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IMF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32472958

Group type: EXPERIMENTAL
Intervention: Dexamethasone (16 mg intravenously at start of surgery)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (4 ml saline)
Number of subjects: 51
Study: 616412020

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36124494

Group type: EXPERIMENTAL
Intervention: BCG vaccine (low dose 0.01 mg and high dose 0.1 mg)
Number of subjects: 4436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 4436
Study: 33397376

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 154
Study: 32270179

Group type: EXPERIMENTAL
Intervention: Sufficient 25(OH)D (≥32 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insufficient 25(OH)D (<32 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Offspring with asthma at age 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Offspring without asthma at age 3
Number of subjects: 0
Study: 35413905

Group type: EXPERIMENTAL
Intervention: Intraperitoneal normal saline instillation (INSI) of 15 mL/kg body weight
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional combination of open laparoscopic trocar valves with gentle abdominal pressure
Number of subjects: 68
Study: 33539742

Group type: EXPERIMENTAL
Intervention: Standard combined-modality treatment (2 + 2 regimen followed by 30 Gy involved-field radiotherapy)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: PET4-guided treatment (2 + 2 regimen followed by 30 Gy of involved-node radiotherapy only if PET positive)
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Standard combined-modality treatment
Number of subjects: 1100

Group type: COMPARATOR
Intervention: PET4-guided treatment
Number of subjects: 1100
Study: 34569991

Group type: EXPERIMENTAL
Intervention: Temperature extremes (minimum temperature <0 °C or maximum temperature >25 °C)
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Season (spring, summer, fall, winter)
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Temperature extremes and season
Number of subjects: 1598
Study: 34185855

Group type: EXPERIMENTAL
Intervention: Neurodynamic nerve gliding (NDNG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Foam rolling (FR)
Number of subjects: 15
Study: 36267888

Group type: EXPERIMENTAL
Intervention: Non-immersive virtual reality (VR) intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional therapies (CT)
Number of subjects: 44
Study: 32866432

Group type: EXPERIMENTAL
Intervention: KRd regimen (36 mg/m2 of intravenous carfilzomib, 25 mg of oral lenalidomide, 40 mg of oral dexamethasone)
Number of subjects: 1087

Group type: COMPARATOR
Intervention: VRd regimen (1.3 mg/m2 of bortezomib, 25 mg of oral lenalidomide, 20 mg of oral dexamethasone)
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: KRd regimen
Number of subjects: 1087

Group type: COMPARATOR
Intervention: VRd regimen
Number of subjects: 1087
Study: 34581703

Group type: EXPERIMENTAL
Intervention: Bright light therapy (10,000 lux) for 30 minutes in the early morning
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 56
Study: 35528160

Group type: EXPERIMENTAL
Intervention: S. boulardii in addition to bismuth quadruple therapy (BQT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: bismuth quadruple therapy (BQT)
Number of subjects: 180
Study: 35191643

Group type: EXPERIMENTAL
Intervention: HFJV
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: LMA
Number of subjects: 75

Group type: COMPARATOR
Intervention: ETT
Number of subjects: 75
Study: 34815540

Group type: EXPERIMENTAL
Intervention: Tailored approach to informing relatives (probands preferred to inform relatives themselves or by genetic counsellor)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Current practice (control group)
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Tailored approach to informing relatives
Number of subjects: 482
Study: 33789481

Group type: EXPERIMENTAL
Intervention: Vascular impulse technology (VIT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Elevation (control)
Number of subjects: 100
Study: 33740060

Group type: EXPERIMENTAL
Intervention: Genetically predicted iron concentration
Number of subjects: 125915

Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin B‐12 concentration
Number of subjects: 125915

Group type: EXPERIMENTAL
Intervention: Genetically predicted selenium concentration
Number of subjects: 125915

Group type: EXPERIMENTAL
Intervention: Genetically predicted zinc concentration
Number of subjects: 125915

Group type: EXPERIMENTAL
Intervention: Genetically predicted concentrations of β‐carotene, calcium, copper, folate, magnesium, phosphorus, and vitamin B‐6
Number of subjects: 125915
Study: 35851956

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (8-week duration)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 69
Study: 34449866

Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 33

Group type: COMPARATOR
Intervention: i-view
Number of subjects: 33
Study: 36394261

Group type: EXPERIMENTAL
Intervention: Mini-sternotomy AVR
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional median sternotomy AVR
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 270
Study: 33006220

Group type: EXPERIMENTAL
Intervention: Reinforcement message (RM) provided by a hospital pharmacist for 10 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care (Control group)
Number of subjects: 40
Study: 32981123

Group type: EXPERIMENTAL
Intervention: BMI with a telephone booster
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 596

Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 596
Study: 35914961

Group type: EXPERIMENTAL
Intervention: $1,000 cash reward policy
Number of subjects: 3698

Group type: EXPERIMENTAL
Intervention: Employer mandates
Number of subjects: 3698

Group type: EXPERIMENTAL
Intervention: Other mandate policies
Number of subjects: 3698

Group type: COMPARATOR
Intervention: Financial incentives (lotteries and cash)
Number of subjects: 3698
Study: 32044260

Group type: EXPERIMENTAL
Intervention: Volar locking plate intervention in elderly patients
Number of subjects: 116

Group type: COMPARATOR
Intervention: Volar locking plate intervention in younger patients
Number of subjects: 116
Study: 35181350

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Dapa)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard treatment (Con)
Number of subjects: 52
Study: 34128075

Group type: EXPERIMENTAL
Intervention: Early cardioversion (1 to 5 days from hospitalization)
Number of subjects: 1039

Group type: COMPARATOR
Intervention: Delayed cardioversion (21 to 56 days from hospitalization)
Number of subjects: 1039

Group type: EXPERIMENTAL
Intervention: CHADS2 score of 0
Number of subjects: 1039

Group type: EXPERIMENTAL
Intervention: Spontaneous restoration of sinus rhythm
Number of subjects: 1039
Study: 32558215

Group type: EXPERIMENTAL
Intervention: Qualitative observations
Number of subjects: 357
Study: 35362362

Group type: EXPERIMENTAL
Intervention: Single one-hour visit to a health coach (n=52)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No intervention (Control group, n=53)
Number of subjects: 105
Study: 33621350

Group type: EXPERIMENTAL
Intervention: 3D multipath DenseNet
Number of subjects: 258

Group type: COMPARATOR
Intervention: 3D singlepath DenseNet
Number of subjects: 258
Study: 32735501

Group type: EXPERIMENTAL
Intervention: Pramipexole combined with levodopa
Number of subjects: 160

Group type: COMPARATOR
Intervention: Levodopa alone
Number of subjects: 160
Study: 35815287

Group type: EXPERIMENTAL
Intervention: Aromatherapy (three drops of rosemary essential oil during SWL)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Music Therapy (soft music played during SWL)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Combined Music Therapy and Aromatherapy (soft music and three drops of rosemary essential oil during SWL)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control (three drops of aromatic distilled water during SWL)
Number of subjects: 176
Study: 32744424

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conventional nasal cannula (CNC)
Number of subjects: 170
Study: 32510696

Group type: EXPERIMENTAL
Intervention: 750 mg/kg/day of SENO
Number of subjects: 65

Group type: COMPARATOR
Intervention: 750 mg/kg/day of placebo-control
Number of subjects: 65
Study: 34332946

Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS (n = 1,507)
Number of subjects: 3020

Group type: COMPARATOR
Intervention: 6- to 12-month DAPT after BP-DES (n = 1,513)
Number of subjects: 3020

Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS
Number of subjects: 3020

Group type: COMPARATOR
Intervention: 6- to 12-month DAPT after BP-DES
Number of subjects: 3020
Study: 33267827

Group type: EXPERIMENTAL
Intervention: CHAPS intervention
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: CHAPS nurse care managers
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Notebook self-care tool
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Siebens Domain Management Model
Number of subjects: 5
Study: 34919121

Group type: EXPERIMENTAL
Intervention: Nurse practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physicians
Number of subjects: 0
Study: 33285722

Group type: EXPERIMENTAL
Intervention: Nursing care and follow-up program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33794724

Group type: EXPERIMENTAL
Intervention: Healthy-donor-stool transplant
Number of subjects: 9

Group type: COMPARATOR
Intervention: Self-stool transplant (control)
Number of subjects: 9
Study: 33648915

Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 0
Study: 35254169

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) follow-up via videoconferencing
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) follow-up
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard follow-up (SF)
Number of subjects: 122
Study: 33006975

Group type: EXPERIMENTAL
Intervention: Student’s t based compound distributions (six types)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GARCH models with innovations following the compound distributions
Number of subjects: 0
Study: 36013257

Group type: EXPERIMENTAL
Intervention: Intraoperative pectoralis nerve II block (PECS II block)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 32331006

Group type: EXPERIMENTAL
Intervention: OLZ/SAM (olanzapine/samidorphan)
Number of subjects: 281
Study: 34187835

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard care plus Monitoring Only
Number of subjects: 282
Study: 33372081

Group type: EXPERIMENTAL
Intervention: Behavioural change intervention (dietary, physical activity, and sedentary behaviours) delivered by dietitians over 12 weeks.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 21
Study: 33423188

Group type: EXPERIMENTAL
Intervention: Bushen Yiqi Huoxue Decoction (BYHD)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Zuogui Pill
Number of subjects: 180

Group type: COMPARATOR
Intervention: Progynova and Duphaston (E+D)
Number of subjects: 180
Study: 32462670

Group type: EXPERIMENTAL
Intervention: ICD/SL intervention applied in groups 2018/2 and 2019/1
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (2018/1) without ICD/SL
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: ICD/SL intervention
Number of subjects: 191
Study: 36114537

Group type: EXPERIMENTAL
Intervention: Experimental arm (six-month intervention combining hard levers - free access to transport/bikes, and soft levers - personalized transport advice)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control arm (six-month intervention aimed at raising awareness on air pollution and its health effects)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both arms (evaluation weeks based on GPS, accelerometer, and pollution sensor)
Number of subjects: 300
Study: 33305369

Group type: COMPARATOR
Intervention: NSAID users (n = 655)
Number of subjects: 2999
Study: 35345897

Group type: EXPERIMENTAL
Intervention: Robotic self-training (ReoGo-J) plus conventional therapy (robotic therapy)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Conventional self-training plus conventional therapy (control)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Robotic self-training plus constraint-induced movement therapy
Number of subjects: 129
Study: 33772279

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 330

Group type: COMPARATOR
Intervention: Observation after adjuvant chemotherapy
Number of subjects: 330
Study: 32865357

Group type: COMPARATOR
Intervention: Conventional subgingival scaling and root planing (SRP) (n=7, 408 sites)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SRP using periodontal endoscope (n=4, 188 sites)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SRP with periodontal endoscope 3 months after initial SRP (n=2, 142 sites)
Number of subjects: 13
Study: 35666651

Group type: EXPERIMENTAL
Intervention: Peer-led navigation (PLNav) intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 45
Study: 32430524

Group type: EXPERIMENTAL
Intervention: PL group (laparoscopic approach)
Number of subjects: 149

Group type: COMPARATOR
Intervention: M group (midline incision)
Number of subjects: 149

Group type: COMPARATOR
Intervention: L group (conventional inverted L incision)
Number of subjects: 149

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 149
Study: 32034769

Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 404

Group type: COMPARATOR
Intervention: No PET-CT
Number of subjects: 404
Study: 33271506

Group type: EXPERIMENTAL
Intervention: Moderate-intensity interval training
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Low-intensity continuous training
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training plus interval training
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 197
Study: 36074149

Group type: EXPERIMENTAL
Intervention: ImmunoPET with [89Zr]Zr‐DFO‐ATZ
Number of subjects: 4
Study: 35851754

Group type: EXPERIMENTAL
Intervention: Telitacicept 240 mg every week for 46 times after plasma exchange
Number of subjects: 8
Study: 34504196

Group type: EXPERIMENTAL
Intervention: Oral rifaximin (550 mg twice daily for 7-10 or 14-21 days preoperatively and 7 days postoperatively)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Oral rifaximin
Number of subjects: 35
Study: 35078666

Group type: EXPERIMENTAL
Intervention: TAK-003 (DENV-2-based dengue tetravalent vaccine candidate)
Number of subjects: 67
Study: 35321144

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) 2x1 min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) 2x3 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no foam rolling)
Number of subjects: 20
Study: 35072713

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 1273

Group type: EXPERIMENTAL
Intervention: HFNO
Number of subjects: 1273

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 1273
Study: 34793638

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 63
Study: 34534232

Group type: EXPERIMENTAL
Intervention: 0.35% ropivacaine with a volume of 14ml for male patients
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 0.353% ropivacaine with a volume of 12ml for female patients
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 0.4% ropivacaine with a volume of 14ml for male and 12ml for female
Number of subjects: 101
Study: 32501546

Group type: COMPARATOR
Intervention: SBP control at less than 50% of visits
Number of subjects: 6591

Group type: EXPERIMENTAL
Intervention: SBP control at 50% to less than 75% of visits
Number of subjects: 6591

Group type: EXPERIMENTAL
Intervention: SBP control at 75% to less than 100% of visits
Number of subjects: 6591

Group type: EXPERIMENTAL
Intervention: SBP control at 100% of visits
Number of subjects: 6591
Study: 35698194

Group type: EXPERIMENTAL
Intervention: CARST (computer-aided reconstruction of soft tissue)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional soft tissue reconstruction
Number of subjects: 30
Study: 33554343

Group type: EXPERIMENTAL
Intervention: amiRNA targeting CBF transcription factors
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: amiRNA targeting ERF34 and ERF35 transcription factors
Number of subjects: 6
Study: 32265495

Group type: EXPERIMENTAL
Intervention: Chitosan tampon (Hemoblock‐Tampon)
Number of subjects: 61
Study: 33563100

Group type: EXPERIMENTAL
Intervention: Smartphone training intervention
Number of subjects: 26
Study: 34024754

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual-treatment
Number of subjects: 99
Study: 35475907

Group type: COMPARATOR
Intervention: 15 g oral glucose (CHO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 80 µg dasiglucagon (D80)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 120 µg dasiglucagon (D120)
Number of subjects: 20
Study: 35644368

Group type: EXPERIMENTAL
Intervention: Health coaching for parents of CMCs (3-6 months)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125